Testing safety of KSHN001034 in healthy postmenopausal women
Treatments studied
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy, postmenopausal women aged 45 to 60
- Body mass index between 18 and 30
- At least 12 months since your last period, or if under 50, a blood test confirming menopause
- Able to give blood samples and follow study procedures
- No major health issues like heart, liver, or bleeding problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety of a new medicine called IMC-003. It is for healthy women who have gone through menopause. You may be able to join if you are between 45 and 75 years old and meet certain health criteria.
This study tests a single dose of the investigational drug BL0175 in healthy postmenopausal women. It aims to see how safe the drug is and how the body processes it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new drug combination (SHR-A1811 with fulvestrant, with or without HS-10352) for women with advanced or metastatic breast cancer that has not been treated with systemic therapy before. It aims to see if these drugs can help slow or stop the cancer's growth.
This trial tests a new drug called HRS-6209 combined with other treatments for people with breast cancer that has worsened after previous therapy. It aims to find a more effective way to control the cancer.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
Hear when a new Healthy Postmenopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.